(KER) Kering - Ratings and Ratios
Fashion, Leather, Jewelry, Accessories, Beauty, Watches, Eyewear, Cosmetics
Description: KER Kering
Kering SA is a global luxury group that manages a portfolio of prestigious brands across fashion, leather goods, and jewelry. The companys diverse brand portfolio includes iconic names such as Gucci, Saint Laurent, and Bottega Veneta, among others. Kerings product offerings span ready-to-wear, accessories, beauty products, leather goods, shoes, watches, jewelry, eyewear, and fragrances.
From a strategic perspective, Kerings focus on luxury goods positions it for long-term growth, driven by increasing demand from emerging markets and a loyal customer base. Key performance indicators (KPIs) to watch include revenue growth, gross margin expansion, and brand momentum. Notably, Kerings brands have shown resilience in the face of global economic uncertainty, with some experiencing significant growth in e-commerce and digital channels.
To evaluate Kerings financial health, we can examine metrics such as Return on Equity (RoE) and the Price-to-Earnings (P/E) ratio. With a RoE of 27.63%, Kering demonstrates a strong ability to generate profits from shareholder equity. The P/E ratio of 21.43 suggests that the stock is reasonably valued relative to its earnings. Additionally, the forward P/E ratio of 30.12 implies expected earnings growth, potentially driven by Kerings ongoing brand investments and strategic initiatives.
From a valuation perspective, Kerings market capitalization stands at approximately 24.6 billion EUR, indicating a significant presence in the global luxury market. As a Trading Analyst, its essential to monitor Kerings financial performance, brand trajectory, and industry trends to identify potential investment opportunities or risks.
KER Stock Overview
| Market Cap in USD | 34,689m |
| Sub-Industry | Apparel, Accessories & Luxury Goods |
| IPO / Inception |
KER Stock Ratings
| Growth Rating | -49.6% |
| Fundamental | 68.9% |
| Dividend Rating | 49.4% |
| Return 12m vs S&P 500 | -6.71% |
| Analyst Rating | - |
KER Dividends
| Dividend Yield 12m | 2.62% |
| Yield on Cost 5y | 1.19% |
| Annual Growth 5y | 11.84% |
| Payout Consistency | 98.1% |
| Payout Ratio | 82.6% |
KER Growth Ratios
| Growth Correlation 3m | 93.7% |
| Growth Correlation 12m | -38.5% |
| Growth Correlation 5y | -86.8% |
| CAGR 5y | -16.17% |
| CAGR/Max DD 3y | -0.22 |
| CAGR/Mean DD 3y | -0.43 |
| Sharpe Ratio 12m | -0.37 |
| Alpha | -12.78 |
| Beta | 0.991 |
| Volatility | 40.25% |
| Current Volume | 196.4k |
| Average Volume 20d | 235.3k |
| Stop Loss | 231.6 (-4%) |
| Signal | 0.68 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (2.81b TTM) > 0 and > 6% of Revenue (6% = 2.05b TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -2.50pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 8.09% (prev 11.59%; Δ -3.50pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 7.10b > Net Income 2.81b (YES >=105%, WARN >=100%) |
| Net Debt (15.65b) to EBITDA (9.63b) ratio: 1.62 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (122.7m) change vs 12m ago 0.27% (target <= -2.0% for YES) |
| Gross Margin 74.29% (prev 75.21%; Δ -0.92pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 88.40% (prev 87.17%; Δ 1.23pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.70 (EBITDA TTM 9.63b / Interest Expense TTM 1.18b) >= 6 (WARN >= 3) |
Altman Z'' 3.71
| (A) 0.07 = (Total Current Assets 11.33b - Total Current Liabilities 8.56b) / Total Assets 42.43b |
| (B) 0.35 = Retained Earnings (Balance) 14.90b / Total Assets 42.43b |
| (C) 0.14 = EBIT TTM 5.53b / Avg Total Assets 38.70b |
| (D) 1.12 = Book Value of Equity 30.03b / Total Liabilities 26.82b |
| Total Rating: 3.71 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 68.90
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 8.28% = 4.14 |
| 3. FCF Margin 10.17% = 2.54 |
| 4. Debt/Equity 0.99 = 2.03 |
| 5. Debt/Ebitda 1.51 = 0.93 |
| 6. ROIC - WACC 7.28% = 9.10 |
| 7. RoE 18.77% = 1.56 |
| 8. Rev. Trend -25.00% = -1.25 |
| 9. Rev. CAGR -2.90% = -0.48 |
| 10. EPS Trend -7.16% = -0.18 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of KER shares?
Over the past week, the price has changed by +1.00%, over one month by +13.96%, over three months by +25.10% and over the past year by +10.32%.
Is Kering a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of KER is around 218.09 EUR . This means that KER is currently overvalued and has a potential downside of -9.62%.
Is KER a buy, sell or hold?
What are the forecasts/targets for the KER price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 205 | -15% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 240.9 | -0.1% |
KER Fundamental Data Overview
Market Cap EUR = 29.58b (29.58b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 2.13b EUR (last quarter)
P/E Trailing = 40.6914
P/E Forward = 24.57
P/S = 1.8767
P/B = 1.9852
P/EG = 2.1887
Beta = 1.118
Revenue TTM = 34.21b EUR
EBIT TTM = 5.53b EUR
EBITDA TTM = 9.63b EUR
Long Term Debt = 10.57b EUR (from longTermDebt, last quarter)
Short Term Debt = 4.01b EUR (from shortTermDebt, last quarter)
Debt = 14.58b EUR (Calculated: Short Term 4.01b + Long Term 10.57b)
Net Debt = 15.65b EUR (from netDebt column, last quarter)
Enterprise Value = 42.03b EUR (29.58b + Debt 14.58b - CCE 2.13b)
Interest Coverage Ratio = 4.70 (Ebit TTM 5.53b / Interest Expense TTM 1.18b)
FCF Yield = 8.28% (FCF TTM 3.48b / Enterprise Value 42.03b)
FCF Margin = 10.17% (FCF TTM 3.48b / Revenue TTM 34.21b)
Net Margin = 8.20% (Net Income TTM 2.81b / Revenue TTM 34.21b)
Gross Margin = 74.29% ((Revenue TTM 34.21b - Cost of Revenue TTM 8.79b) / Revenue TTM)
Tobins Q-Ratio = 1.40 (Enterprise Value 42.03b / Book Value Of Equity 30.03b)
Interest Expense / Debt = 2.19% (Interest Expense 319.0m / Debt 14.58b)
Taxrate = 27.15% (461.0m / 1.70b)
NOPAT = 4.03b (EBIT 5.53b * (1 - 27.15%))
Current Ratio = 1.32 (Total Current Assets 11.33b / Total Current Liabilities 8.56b)
Debt / Equity = 0.99 (Debt 14.58b / last Quarter total Stockholder Equity 14.77b)
Debt / EBITDA = 1.51 (Net Debt 15.65b / EBITDA 9.63b)
Debt / FCF = 4.19 (Debt 14.58b / FCF TTM 3.48b)
Total Stockholder Equity = 14.95b (last 4 quarters mean)
RoA = 6.61% (Net Income 2.81b, Total Assets 42.43b )
RoE = 18.77% (Net Income TTM 2.81b / Total Stockholder Equity 14.95b)
RoCE = 21.68% (Ebit 5.53b / (Equity 14.95b + L.T.Debt 10.57b))
RoIC = 14.28% (NOPAT 4.03b / Invested Capital 28.21b)
WACC = 7.00% (E(29.58b)/V(44.16b) * Re(9.67%)) + (D(14.58b)/V(44.16b) * Rd(2.19%) * (1-Tc(0.27)))
Shares Correlation 3-Years: -72.73 | Cagr: -0.20%
Discount Rate = 9.67% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 68.02% ; FCFE base≈3.59b ; Y1≈2.85b ; Y5≈1.90b
Fair Price DCF = 222.3 (DCF Value 27.25b / Shares Outstanding 122.6m; 5y FCF grow -24.62% → 3.0% )
Revenue Correlation: -25.00 | Revenue CAGR: -2.90%
Rev Growth-of-Growth: -52.71
EPS Correlation: -7.16 | EPS CAGR: 0.0%
EPS Growth-of-Growth: -60.40